Itsa, yes kudos to you, Sammy, Imp, Mac, Learner and the long termers who have been here from the day of MS and Acro trials.
Those frustrating 'false starts' and data generated...is now unlocking latent shareholder value with DMD.
Not many Phase 2B 'pivotal' trials going on where efficacy end points were already proven in P2.
We are one 12 month trial away from market approval - just have to replicate P2 results.
Still lots of risk - but we know the 25Mg dosing arm will work!
That will be the supporting pillar for approval - while we find the 'goldilocks' higher dose.
"Steady pace" for share price appreciation?
Not sure - there will be a 'gap up' and some....to reflect the de-risking occurring now.
I'm looking at the +$1.70 un-risked valuation in the analyst reports as the beacon once funding is announced.
We'll get there in the new year imo.
.
- Forums
- ASX - By Stock
- PER
- Ann: Trading Halt
Ann: Trading Halt, page-91
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 8.0¢ | $3.675K | 45.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 343 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 343 | 0.080 |
1 | 24999 | 0.079 |
3 | 78158 | 0.078 |
1 | 13844 | 0.077 |
1 | 8000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 10000 | 1 |
0.083 | 281992 | 3 |
0.084 | 100000 | 1 |
0.085 | 136669 | 3 |
0.086 | 135412 | 3 |
Last trade - 14.33pm 09/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |